Company: NXNVW
Filing Date: 2025-04-25
Form Type: S-3
Source: 0001213900-25-035543
Chunk: 20

Company: NEXTNAV INC.
Filing Date: 2025-04-25
Form: S-3
Chunk 20
---
 otherwise required by law or our charter (including any preferred stock designation), (i) the holders of Common Stock possess all voting power with respect to the Company and (ii) each outstanding share of Common Stock entitles the holder to one vote on any matter properly submitted to the stockholders. Preemptive Rights Holders of outstanding shares of our Common Stock are not entitled to preemptive or other similar subscription rights to purchase any of our securities. Conversion or Redemption Rights Our Common Stock is neither convertible nor redeemable. Liquidation Rights Subject to applicable law and the rights, if any, of the holders of any outstanding series of the preferred stock upon our liquidation, the holders of our Common Stock are entitled to receive all of our remaining assets available for distribution to our stockholders, ratably in proportion to the number of shares of our Common Stock held by each stockholder. Preferred Stock Our Board may, without further action by our stockholders, from time to time, direct the issuance of up to 100,000,000 shares of preferred stock in one or more series and may, at the time of issuance, fix the voting powers, if any, and determine the designations, powers, preferences, and relative, participating, optional, special and other rights, if any, of each such series and any qualifications, limitations and restrictions thereof. Accordingly, our Board, without stockholder approval, may issue preferred stock with voting, conversion, or other rights that could adversely affect the voting power and other rights of the holders of our Common Stock. Preferred stock could be issued quickly with terms calculated to delay or prevent a change of control or make removal of management more difficult. Additionally, the issuance of preferred stock may have the effect of decreasing the market price of our Common Stock, may adversely affect the voting and other rights of the holders of our Common Stock, and could have the effect of delaying, deferring or preventing a change of control of us or other corporate action.

| 14 |

Warrants Registered Warrants On March 12, 2025 , we entered into the Note Purchase Agreement pursuant to which we, among other things, agreed to sell to the purchasers in a private placement the Registered Warrants. We subsequently issued 7,800,000 of the Registered Warrants on March 27, 2025 . The Registered Warrants have exercise price s ranging from $12.56 to $20.00 per share as follows: (i) 2,900,000 Registered Warrants have an exercise price of $12.